Maynard Um
-
-
-
-
-
-
-
Ligand Pharma (LGND) to buy Xoma for ~$740M - WSJ
-
-
-
-
-
-
-
Stifel on Ligand Pharma (LGND): 'positioned for continued traction owing to MRK’s new ownership of Ohtuvayre'
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $234 at RBC Capital
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $160 at Benchmark On Model Adjustment
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Ligand Pharma (LGND)
-
-
-
-
-
-
-
Ligand Pharma (LGND) Tops Q4 EPS by 9c ; Offers Guidance
-
-
-
-
-
-
-
Ligand Pharma (LGND) Tops Q3 EPS by 50c ; Offers Guidance
-
401,645 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

